| CTRI Number |
CTRI/2025/04/084897 [Registered on: 16/04/2025] Trial Registered Prospectively |
| Last Modified On: |
16/04/2025 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
A clinical trial to compare preoperative administration of pregabalin and duloxetine for postoperative pain |
|
Scientific Title of Study
|
Comparison of preoperative administration of pregabalin and duloxetine for postoperative pain |
| Trial Acronym |
Nil |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Gurpreeti Kaur |
| Designation |
Associate Professor |
| Affiliation |
Dayanand Medical College and Hospital |
| Address |
Department of anaesthesiology Dayanand Medical College and hospital Ludhiana Punjab
Ludhiana PUNJAB 141001 India |
| Phone |
9779552017 |
| Fax |
|
| Email |
grewal.preeti@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Manpreet Kaur |
| Designation |
PG resident anaesthesia |
| Affiliation |
Dayanand medical college and hospital Ludhiana Punjab |
| Address |
Department of anaesthesiology Dayanand Medicall college and hospital Ludhiana Punjab 141001
Ludhiana PUNJAB 141001 India |
| Phone |
7985357174 |
| Fax |
|
| Email |
mkaur2585@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Manpreet Kaur |
| Designation |
PG resident Anaesthesia |
| Affiliation |
Dayanand medical college and hospital Ludhiana Punjab 141001 |
| Address |
Department of anaesthesiology Dayanand medical college and hospital Ludhiana Punjab
Ludhiana PUNJAB 141001 India |
| Phone |
7986357174 |
| Fax |
|
| Email |
mkaur2585@gmail.com |
|
|
Source of Monetary or Material Support
|
| Dayanand medical college and hospital Ludhiana Punjab India 141001 |
|
|
Primary Sponsor
|
| Name |
Dayanand medical college and hospital Ludhiana Punjab |
| Address |
Tagore nagar Civil Lines Ludhiana Punjab India 141001 |
| Type of Sponsor |
Private medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Gurpreeti Kaur |
Dayanand medical college and hospital |
Department of anaesthesiology Dayanand medical college and hospital Civil Lines Tagore nagar Ludhiana Punjab 141001 Ludhiana PUNJAB |
9779552017
grewal.preeti@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Research and Ethical committee Dayanand medical college and hospital Ludhiana Punjab |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: K80-K87||Disorders of gallbladder, biliary tract and pancreas, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
Cap Duloxetine 60 mg |
60 mg of capsule Duloxetine orally one hour prior to the surgery for VAS assessment for 24 hrs |
| Comparator Agent |
Cap Pregabalin 75 mg |
75 mg of capsule Pregabalin orally one hour prior to the surgery for VAS assessment for 24 hrs |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
65.00 Year(s) |
| Gender |
Both |
| Details |
1. ASA grade I-III patients
2. Adult patients (18-65 years)
3. Either gender
4. Patients scheduled for laparoscopic cholecystectomy under general anaesthesia. |
|
| ExclusionCriteria |
| Details |
1. Patient with known allergy to any of the study drug
2. ASA grade IV or more
3. Patients with underlying psychiatric disorders
4. Patients on antiepileptics or MAO inhibitors
5. Patients on chronic pain medications
6. Patients with H/O SIADH
• Patients with H/O syncope
• Lactating and pregnant females
• Patient refusal
|
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Participant and Investigator Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| To compare the analgesic efficacy of oral Pregabalin and Duloxetine using VAS score |
VAS score at PACU at 0 minutes (on shifting to PACU), 1, 2, 4, 8, 12, 24 hours postoperatively |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
1. To compare the consumption of total rescue analgesic in first 24 hours postoperatively
2. Postoperative sedation using five point NSS scale
3. The frequency of postoperative nausea & vomiting using four point PONV Scale |
Postoperative sedation & postoperative nausea & vomiting at 0 min(on shifting to PACU) 1, 2,4,8,12,24 hours.Time to first rescue analgesia & total amount of rescue analgesia required in first 24 hours postoperatively |
|
|
Target Sample Size
|
Total Sample Size="260" Sample Size from India="260"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
27/04/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="6" Days="29" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
The pain pattern after laparoscopic cholecystectomy is complex and distinct from postoperative pain after other laparoscopic procedures, suggesting that procedure specific optimal analgesic management plans should be proposed. Duloxetine is a SNRI which is being used as an adjunct for management of neuropathic pain and attenuation of postoperative pain especially in lower limb surgeries. Pregabalin ,a structural analogue of GABA , reduces opioid consumption and postoperative pain after major surgeries. However, the comparison of these drugs on global postoperative quality of recovery in laparoscopic surgeries has yet to be evaluated. An interventional randomised study will be conducted in 260 adult patients of American Society of Anesthesiologists(ASA) grade I-III aged 18-65 years scheduled for laparoscopic cholecystectomy under general anesthesia who will be randomly and equally divided into two groups I,II. Group I 130 patients will be administered preoperatively 75 mg of capsulePregabalin orally and group II 130 patients 60 mg of capsule Duloxetine orally one hour prior to the surgery. Postoperative analgesic efficacy will be compared in both the two groups by using VAS score at 0 min, 1,2,4,8,12,24 hours along with assessment of sedation using Numeric Sedation Scale at 0,1,2,4,8,12 and 24 hours, time to first rescue analgesia and total amount of rescue analgesia required in first 24 hours. |